Healthpeak Properties (DOC) AI Stock Analysis

• Market Cap: $12.04B
• Dividend Yield: 7.82%
• Average Volume (3M): 7.37M
• Price to Earnings (P/E): 72.3
• Beta (1Y): 0.62
• Revenue Growth: 15.91%
• EPS Growth: -49.49%
• Country: US
• Employees: 387
• Sector: Real Estate
• Sector Strength: 55
• Industry: REIT - Healthcare Facilities
• EPS (TTM): 0.05
• Shares Outstanding: 694,923,460
• 10 Day Avg. Volume: 10,355,474
• 30 Day Avg. Volume: 7,366,015
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: 1.83
• Enterprise Value/Revenue: 7.88
• Enterprise Value/Gross Profit: 13.04
• Enterprise Value/Ebitda: 13.80
• 1Y Price Target: $20.54
• Price Target Upside: 22.48% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 13

• Rating: 66 Neutral
• Price Target: $18.50 ▲(10.32% Upside)

Healthpeak Properties shows a solid financial foundation with robust revenue growth and cash generation, though profitability and technical weakness limit the score. Positive earnings call sentiment and a strong dividend yield enhance the attractiveness, but high valuation and bearish technical indicators are concerns.

Positive Factors

Capital Markets

Both ARE and DOC called out a recent positive shift in the capital markets for Life Science.

Partnership and Growth

DOC announced a new partnership with Hines, indicating potential growth and collaboration opportunities.

Stock Buybacks

The company repurchased $94 million in shares year-to-date, signaling confidence in its own stock value.

Negative Factors

Life Science Market Challenges

There is an expected deceleration in lab SSNOI growth, reflecting challenges in the Life Science market.

Occupancy Challenges

Occupancy results were a disappointment for both, resulting from users of space facing continued headwinds from capital raising and lingering impacts from regulatory concerns.

Regulatory Concerns

Lab uncertainty will likely continue to weigh on the shares.

Healthpeak Properties Business Overview & Revenue Model

Company Description

Healthpeak Properties, Inc. (DOC) is a real estate investment trust (REIT) that focuses on the healthcare sector. The company primarily invests in properties that cater to the needs of the aging population, including senior housing, life science facilities, and medical offices. Healthpeak aims to create long-term value by strategically acquiring, developing, and managing healthcare properties that are essential for delivering high-quality care.

How the Company Makes Money

Healthpeak Properties generates revenue primarily through rental income from its diverse portfolio of healthcare-related properties. The company leases its properties to various healthcare operators and service providers, benefiting from long-term leases that often include rent escalations over time. Key revenue streams include senior housing operations, where Healthpeak collects rental payments from residents; life science facilities, where tenants are typically biotech and pharmaceutical companies; and medical office buildings leased to healthcare providers. Additionally, Healthpeak may engage in property development and redevelopment projects, which can enhance its asset value and yield further income. Significant partnerships with leading healthcare operators and institutions also contribute to the company's stable revenue base and growth potential.

Healthpeak Properties Financial Statement Overview

Summary

Healthpeak Properties demonstrates solid financial health with strong revenue growth and efficient cash flow management. While profitability metrics are improving, high leverage is a potential risk that needs monitoring.

Income Statement

Healthpeak Properties shows a strong revenue growth trajectory with a significant increase from 2024 to TTM (Trailing-Twelve-Months). The gross profit margin remains healthy, indicating good control over cost of sales. While net profit margin shows improvement over time, there is room for optimization in operational efficiency to enhance profitability further.

Balance Sheet

The company's debt-to-equity ratio is relatively high, indicating leveraged operations. However, the return on equity is decent, highlighting effective use of shareholder equity. The equity ratio is stable, suggesting a balanced approach to asset management, but high debt levels could pose future risks.

Cash Flow

Operating cash flow is robust with consistent free cash flow growth, signaling strong cash generation capabilities. The operating cash flow to net income ratio is favorable, demonstrating efficient cash conversion. However, attention to investing and financing activities is recommended to maintain liquidity.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.70B	2.18B	2.06B	1.90B	1.64B
Gross Profit	1.63B	1.28B	1.20B	1.12B	862.33M
EBITDA	1.61B	1.27B	1.39B	970.63M	1.13B
Net Income	243.14M	306.01M	500.45M	505.54M	413.56M
Balance Sheet
Total Assets	19.94B	15.70B	5.10B	5.18B	4.41B
Cash, Cash Equivalents and Short-Term Investments	119.82M	138.99M	126.83M	158.29M	44.23M
Total Debt	9.02B	7.08B	6.71B	6.37B	6.48B
Total Liabilities	10.88B	8.77B	2.10B	2.19B	1.67B
Stockholders Equity	8.40B	6.35B	6.65B	6.52B	6.73B
Cash Flow
Free Cash Flow	1.07B	956.24M	218.53M	214.99M	199.41M
Operating Cash Flow	1.07B	956.24M	258.40M	247.56M	233.30M
Investing Cash Flow	-113.80M	-576.75M	-38.47M	-603.22M	-1.01B
Financing Cash Flow	-941.42M	-337.30M	-222.07M	363.03M	246.45M

Healthpeak Properties Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 16.77
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DOC, the sentiment is Negative. The current price of 16.77 is below the 20-day moving average (MA) of 17.59, below the 50-day MA of 17.53, and below the 200-day MA of 18.94, indicating a bearish trend. The MACD of -0.27 indicates Positive momentum. The RSI at 42.33 is Neutral, neither overbought nor oversold. The STOCH value of 29.69 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DOC.

Healthpeak Properties Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
WELL	77 Outperform	$112.23B	138.80	3.48%	1.64%	30.73%	96.48%
VTR	77 Outperform	$31.92B	158.40	1.81%	2.71%	12.45%	―
OHI	75 Outperform	$11.86B	25.07	10.47%	6.67%	12.73%	23.51%
SBRA	73 Outperform	$4.49B	24.62	6.66%	6.44%	6.89%	240.70%
DOC	66 Neutral	$12.04B	72.26	1.97%	7.82%	15.91%	-49.49%
Sector *	63 Neutral	$6.78B	12.96	-0.54%	7.46%	3.69%	-24.78%
HR	61 Neutral	$5.88B	―	-7.59%	7.41%	-7.16%	23.40%

Healthpeak Properties Corporate Events

Healthpeak Properties Announces $500M Senior Notes Offering

On August 5, 2025, Healthpeak Properties, Inc. announced that its operating company, Healthpeak OP, LLC, entered into an underwriting agreement for a public offering of $500 million in senior unsecured notes due 2033. The net proceeds, estimated at approximately $491.4 million, will be used to repay borrowings under its commercial paper program and for general corporate purposes, including potential acquisitions and capital expenditures. The offering is expected to close on August 14, 2025, and involves several underwriters, with the notes being fully guaranteed by Healthpeak and its affiliates.

The most recent analyst rating on (DOC) stock is a Buy with a $26.00 price target. To see the full list of analyst forecasts on Healthpeak Properties stock, see the DOC Stock Forecast page.

Healthpeak Properties Updates Tax Considerations in SEC Filing

On February 5, 2025, Healthpeak Properties filed a Post-Effective Amendment to a Registration Statement with the SEC, updating the discussion on U.S. federal income tax considerations related to its REIT status and securities offerings. This amendment replaces previous tax considerations and highlights the complexities and potential changes in tax laws affecting REIT qualifications and operations, which could impact Healthpeak’s tax obligations and investor returns.

The most recent analyst rating on (DOC) stock is a Buy with a $26.00 price target. To see the full list of analyst forecasts on Healthpeak Properties stock, see the DOC Stock Forecast page.

Healthpeak Properties Reports Q2 2025 Financial Results

Healthpeak Properties reported its second quarter 2025 financial results, showing a net income of $0.05 per share and a 3.5% growth in Total Merger-Combined Same-Store Cash NOI. The company executed significant lease agreements and entered into new development agreements to support outpatient expansion, while also achieving sustainability milestones and earning prestigious industry awards.

The most recent analyst rating on (DOC) stock is a Buy with a $26.00 price target. To see the full list of analyst forecasts on Healthpeak Properties stock, see the DOC Stock Forecast page.

Healthpeak Properties to Join BofA Healthcare Panel

John Thomas, Vice Chair of Healthpeak Properties, is set to participate in a panel discussion at the BofA Securities 2025 Healthcare Conference on May 14, 2025. This participation highlights Healthpeak’s ongoing engagement with industry events, potentially impacting its visibility and stakeholder relations.

The most recent analyst rating on (DOC) stock is a Buy with a $26.00 price target. To see the full list of analyst forecasts on Healthpeak Properties stock, see the DOC Stock Forecast page.